Epidermal growth factor receptor (EGFR) gene mutations are common biomarkers in non-small cell lung cancer (NSCLC). They affect about 1 in 3 people with NSCLC. About 90% of EGFR mutations are EGFR 19 ...
Epidermal growth factor receptor (EGFR) is a protein on the surface of your cells that helps them grow. When the gene that codes for EGFR has a mutation, it affects the way this protein works, causing ...
Patients with stage 4 lung cancer and EGFR mutations may benefit from combination therapies that improve disease control. The American Society of Clinical Oncology (ASCO) released updated treatment ...
Advanced chondrosarcomas: Role of chemotherapy and survival. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not include a full text component.
Current equations for estimated glomerular filtration rate (eGFR) that use serum creatinine or cystatin C incorporate age, sex, and race to estimate measured GFR. However, race in eGFR equations is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results